NCT00200395View on ClinicalTrials.gov

OSI-774 (Erlotinib, Tarceva) in Elderly Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 2, 2003

Primary Completion Date

January 12, 2007

Study Completion Date

January 12, 2007

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Tarceva

OSI-774 will be supplied as 25 mg (non -film coated) 100 and 150 mg (film coated) tablets in separate bottles, containing 30 tablets respectively.

Trial Locations (4)

10003

Beth Israel Medical Center, New York

10016

New York University, New York

10461

Albert Einstein Cancer Center, The Bronx

10467

Montefiore Medical Center-, The Bronx

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Montefiore Medical Center

OTHER